Praveen Tyle - Net Worth and Insider Trading
Praveen Tyle Net Worth
The estimated net worth of Praveen Tyle is at least $16,797 dollars as of 2024-12-27. Praveen Tyle is the Director of Kiora Pharmaceuticals Inc and owns about 5,014 shares of Kiora Pharmaceuticals Inc (KPRX) stock worth over $16,797. Details can be seen in Praveen Tyle's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Praveen Tyle has not made any transactions after 2024-08-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Praveen Tyle
Praveen Tyle Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Praveen Tyle owns 4 companies in total, including Lexicon Pharmaceuticals Inc (LXRX) , GI Dynamics Inc (GIDYL) , and Kiora Pharmaceuticals Inc (KPRX) among others .
Click here to see the complete history of Praveen Tyle’s form 4 insider trades.
Insider Ownership Summary of Praveen Tyle
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LXRX | Lexicon Pharmaceuticals Inc | 2016-05-16 | EVP & R&D |
| GIDYL | GI Dynamics Inc | 2020-02-28 | director |
| KPRX | Kiora Pharmaceuticals Inc | 2024-08-19 | director |
 | | 2021-07-22 | director |
Praveen Tyle Latest Holdings Summary
Praveen Tyle currently owns a total of 1 stock. Praveen Tyle owns 5,014 shares of Kiora Pharmaceuticals Inc (KPRX) as of August 19, 2024, with a value of $16,797.
Latest Holdings of Praveen Tyle
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KPRX | Kiora Pharmaceuticals Inc | 2024-08-19 | 5,014 | 3.35 | 16,797 |
Holding Weightings of Praveen Tyle
Praveen Tyle Form 4 Trading Tracker
According to the SEC Form 4 filings, Praveen Tyle has made a total of 1 transactions in Kiora Pharmaceuticals Inc (KPRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Kiora Pharmaceuticals Inc is the acquisition of 5,000 shares on August 19, 2024, which cost Praveen Tyle around $19,800.
Insider Trading History of Praveen Tyle
- 1
Praveen Tyle Trading Performance
GuruFocus tracks the stock performance after each of Praveen Tyle's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Praveen Tyle is -20.05%. GuruFocus also compares Praveen Tyle's trading performance to market benchmark return within the same time period. The performance of stocks bought by Praveen Tyle within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Praveen Tyle's insider trading performs compared to the benchmark.
Performance of Praveen Tyle
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.97 | | | | | |
| Relative Return to S&P 500(%) | -9.85 | | | | | |
Praveen Tyle Ownership Network
Praveen Tyle Owned Company Details
What does Lexicon Pharmaceuticals Inc do?
Who are the key executives at Lexicon Pharmaceuticals Inc?
Praveen Tyle is the EVP & R&D of Lexicon Pharmaceuticals Inc. Other key executives at Lexicon Pharmaceuticals Inc include director & President and CEO Lonnel Coats , director & 10 percent owner Raymond Debbane , and SVP & Chief Commercial Officer Thomas Garner .
Lexicon Pharmaceuticals Inc (LXRX) Insider Trades Summary
Over the past 18 months, Praveen Tyle made no insider transaction in Lexicon Pharmaceuticals Inc (LXRX). Other recent insider transactions involving Lexicon Pharmaceuticals Inc (LXRX) include a net purchase of 110,000 shares made by Lonnel Coats , a net purchase of 1,000,000 shares made by Raymond Debbane , and a net purchase of 200,000 shares made by Philippe Amouyal .
In summary, during the past 3 months, insiders sold 0 shares of Lexicon Pharmaceuticals Inc (LXRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lexicon Pharmaceuticals Inc (LXRX) were sold and 1,326,000 shares were bought by its insiders, resulting in a net purchase of 1,326,000 shares.
Lexicon Pharmaceuticals Inc (LXRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lexicon Pharmaceuticals Inc Insider Transactions
Praveen Tyle Mailing Address
Above is the net worth, insider trading, and ownership report for Praveen Tyle. You might contact Praveen Tyle via mailing address: One Bausch & Lomb Place, Rochester Ny 14604.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
